Vincent Anicetti
Equibles does not estimate personal net worth.
About Vincent Anicetti
Earlier roles on record: COO at Coherus Oncology, Inc. (CHRS) until December 31, 2021. The proxy statement of Coherus Oncology, Inc. reports total compensation of $1,810,841 for Vincent Anicetti in fiscal 2019, including a base salary of $469,370. Disclosed compensation is on record for 2 fiscal years. Vincent Anicetti has spoken on 1 earnings call across 1 company, most recently for Coherus Oncology, Inc. on February 24, 2021. The companies whose calls Vincent Anicetti spoke on are classified in the Healthcare sector.
Vincent Anicetti on recent calls
“So with our Humira biosimilar, CHS-1420, as we announced, the FDA accepted that for a review, which means they found everything within the BLA in order and all of the necessary information there.”
Affiliation history
-
Start not stated–2021-12-31
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Coherus Oncology, Inc. (CHRS) | Chief Operating Officer | $469,370 | $1,810,841 |
| 2018 | Coherus Oncology, Inc. (CHRS) | Chief Operating Officer | $418,744 | $1,818,680 |